Macular Edema and Macular Degeneration Market By Treatment Type (Drug Therapy, Laser Treatment) By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration) By End User, Hospitals, Clinics, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: June 2025
Report ID: 150176
Number of Pages: 244
Format:

Fact Checked

Cite this Research

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Macular Edema and Macular Degeneration Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Macular Edema and Macular Degeneration Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Macular Edema and Macular Degeneration Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 3.3. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
    
    3.3.1. Drug Therapy
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Laser Treatment
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
  - 3.4. Global Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 3.5. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
    
    3.5.1. Macular Edema
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Diabetic Macular Edema (DME)
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Cystoid Macular Edema (CME)
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Macular Degeneration
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
    
    3.5.5. Dry age-related macular degeneration
    
    3.5.5.1. Insights
    
    3.5.5.2. Key Takeaways
    
    3.5.6. Wet age-related macular degeneration
    
    3.5.6.1. Insights
    
    3.5.6.2. Key Takeaways
  - 3.6. Global Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 3.7. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
    
    3.7.1. Hospitals
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Clinics
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Others
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
- 4. Global Macular Edema and Macular Degeneration Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Region
- 5. North America Macular Edema and Macular Degeneration Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 5.3. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
  - 5.4. North America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 5.5. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
  - 5.6. North America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 5.7. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
  - 5.8. North America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.9. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Macular Edema and Macular Degeneration Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 6.3. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
  - 6.4. Europe Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 6.5. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
  - 6.6. Europe Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 6.7. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
  - 6.8. Europe Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.9. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Macular Edema and Macular Degeneration Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 7.3. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
  - 7.4. Asia Pacific Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 7.5. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 7.7. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
  - 7.8. Asia Pacific Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.9. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Macular Edema and Macular Degeneration Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 8.3. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
  - 8.4. Latin America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 8.5. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
  - 8.6. Latin America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 8.7. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
  - 8.8. Latin America Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.9. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Macular Edema and Macular Degeneration Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2020-2034
  - 9.3. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
  - 9.4. Middle East & Africa Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 9.5. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 9.7. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
  - 9.8. Middle East & Africa Macular Edema and Macular Degeneration Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.9. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Kubota Pharmaceutical Holdings Co. Ltd
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Alimera Sciences Inc.
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Abbvie Inc.
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Novartis AG
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. F. Hoffmann-La Roche Ltd
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Regeneron Pharmaceuticals Inc.
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Regen X Bio Inc.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. GlaxoSmithKline Plc
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Bayer AG
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Bausch Health Companies Inc.
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 2. Global Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 3. Global Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 4. Global Macular Edema and Macular Degeneration Market Value (US$ Mn), By Region, 2020-2034
- Table 5. North America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 6. North America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 7. North America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 8. North America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Country, 2020-2034
- Table 9. The US Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 10. The US Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 11. The US Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 12. Canada Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 13. Canada Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 14. Canada Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 15. Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 16. Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 17. Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 18. Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Country, 2020-2034
- Table 19. Germany Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 20. Germany Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 21. Germany Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 22. The UK Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 23. The UK Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 24. The UK Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 25. France Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 26. France Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 27. France Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 28. Spain Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 29. Spain Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 30. Spain Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 31. Italy Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 32. Italy Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 33. Italy Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 34. Russia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 35. Russia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 36. Russia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 37. Netherland Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 38. Netherland Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 39. Netherland Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 40. Rest of Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 41. Rest of Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 42. Rest of Europe Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 43. Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 44. Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 45. Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 46. Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Country, 2020-2034
- Table 47. China Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 48. China Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 49. China Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 50. India Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 51. India Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 52. India Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 53. Japan Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 54. Japan Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 55. Japan Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 56. South Korea Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 57. South Korea Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 58. South Korea Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 59. Australia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 60. Australia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 61. Australia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 62. New Zealand Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 63. New Zealand Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 64. New Zealand Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 65. Singapore Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 66. Singapore Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 67. Singapore Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 68. Thailand Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 69. Thailand Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 70. Thailand Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 71. Vietnam Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 72. Vietnam Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 73. Vietnam Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 74. Rest of Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 75. Rest of Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 76. Rest of Asia Pacific Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 77. Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 78. Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 79. Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 80. Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Country, 2020-2034
- Table 81. Brazil Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 82. Brazil Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 83. Brazil Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 84. Mexico Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 85. Mexico Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 86. Mexico Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 87. Rest of Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 88. Rest of Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 89. Rest of Latin America Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 90. Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 91. Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 92. Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 93. Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Country, 2020-2034
- Table 94. South Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 95. South Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 96. South Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 97. Saudi Arabia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 98. Saudi Arabia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 99. Saudi Arabia Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 100. UAE Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 101. UAE Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 102. UAE Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
- Table 103. Rest of Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Treatment Type, 2020-2034
- Table 104. Rest of Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Application, 2020-2034
- Table 105. Rest of Middle East & Africa Macular Edema and Macular Degeneration Market Value (US$ Mn), By Distribution Channel, 2020-2034
List of Figures
- Figure 1. Global Macular Edema and Macular Degeneration Market Snapshot: Market Value (US$ Mn), 2020-2034
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Macular Edema and Macular Degeneration Market
- Figure 5. Global Macular Edema and Macular Degeneration Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 6. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
- Figure 7. Global Macular Edema and Macular Degeneration Market Analysis, By Application, 2020, 2024 and 2034
- Figure 8. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
- Figure 9. Global Macular Edema and Macular Degeneration Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 10. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
- Figure 11. Global Macular Edema and Macular Degeneration Market Analysis, By Region, 2020, 2024 and 2034
- Figure 12. Global Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Region
- Figure 13. North America Macular Edema and Macular Degeneration Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 14. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
- Figure 15. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Drug Therapy, 2020-2034
- Figure 16. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Laser Treatment, 2020-2034
- Figure 17. North America Macular Edema and Macular Degeneration Market Analysis, By Application, 2020, 2024 and 2034
- Figure 18. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
- Figure 19. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Edema, 2020-2034
- Figure 20. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Diabetic Macular Edema (DME), 2020-2034
- Figure 21. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Cystoid Macular Edema (CME), 2020-2034
- Figure 22. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Degeneration, 2020-2034
- Figure 23. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Dry age-related macular degeneration, 2020-2034
- Figure 24. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Wet age-related macular degeneration, 2020-2034
- Figure 25. North America Macular Edema and Macular Degeneration Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 26. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
- Figure 27. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Hospitals, 2020-2034
- Figure 28. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Clinics, 2020-2034
- Figure 29. North America Macular Edema and Macular Degeneration Market (US$ Mn), by Others, 2020-2034
- Figure 30. North America Macular Edema and Macular Degeneration Market Analysis, By Country, 2020, 2024 and 2034
- Figure 31. North America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
- Figure 32. Europe Macular Edema and Macular Degeneration Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 33. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
- Figure 34. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Drug Therapy, 2020-2034
- Figure 35. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Laser Treatment, 2020-2034
- Figure 36. Europe Macular Edema and Macular Degeneration Market Analysis, By Application, 2020, 2024 and 2034
- Figure 37. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
- Figure 38. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Edema, 2020-2034
- Figure 39. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Diabetic Macular Edema (DME), 2020-2034
- Figure 40. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Cystoid Macular Edema (CME), 2020-2034
- Figure 41. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Degeneration, 2020-2034
- Figure 42. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Dry age-related macular degeneration, 2020-2034
- Figure 43. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Wet age-related macular degeneration, 2020-2034
- Figure 44. Europe Macular Edema and Macular Degeneration Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 45. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
- Figure 46. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Hospitals, 2020-2034
- Figure 47. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Clinics, 2020-2034
- Figure 48. Europe Macular Edema and Macular Degeneration Market (US$ Mn), by Others, 2020-2034
- Figure 49. Europe Macular Edema and Macular Degeneration Market Analysis, By Country, 2020, 2024 and 2034
- Figure 50. Europe Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
- Figure 51. Asia Pacific Macular Edema and Macular Degeneration Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 52. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
- Figure 53. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Drug Therapy, 2020-2034
- Figure 54. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Laser Treatment, 2020-2034
- Figure 55. Asia Pacific Macular Edema and Macular Degeneration Market Analysis, By Application, 2020, 2024 and 2034
- Figure 56. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
- Figure 57. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Edema, 2020-2034
- Figure 58. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Diabetic Macular Edema (DME), 2020-2034
- Figure 59. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Cystoid Macular Edema (CME), 2020-2034
- Figure 60. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Degeneration, 2020-2034
- Figure 61. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Dry age-related macular degeneration, 2020-2034
- Figure 62. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Wet age-related macular degeneration, 2020-2034
- Figure 63. Asia Pacific Macular Edema and Macular Degeneration Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 64. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
- Figure 65. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Hospitals, 2020-2034
- Figure 66. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Clinics, 2020-2034
- Figure 67. Asia Pacific Macular Edema and Macular Degeneration Market (US$ Mn), by Others, 2020-2034
- Figure 68. Asia Pacific Macular Edema and Macular Degeneration Market Analysis, By Country, 2020, 2024 and 2034
- Figure 69. Asia Pacific Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
- Figure 70. Latin America Macular Edema and Macular Degeneration Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 71. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
- Figure 72. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Drug Therapy, 2020-2034
- Figure 73. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Laser Treatment, 2020-2034
- Figure 74. Latin America Macular Edema and Macular Degeneration Market Analysis, By Application, 2020, 2024 and 2034
- Figure 75. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
- Figure 76. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Edema, 2020-2034
- Figure 77. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Diabetic Macular Edema (DME), 2020-2034
- Figure 78. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Cystoid Macular Edema (CME), 2020-2034
- Figure 79. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Degeneration, 2020-2034
- Figure 80. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Dry age-related macular degeneration, 2020-2034
- Figure 81. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Wet age-related macular degeneration, 2020-2034
- Figure 82. Latin America Macular Edema and Macular Degeneration Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 83. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
- Figure 84. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Hospitals, 2020-2034
- Figure 85. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Clinics, 2020-2034
- Figure 86. Latin America Macular Edema and Macular Degeneration Market (US$ Mn), by Others, 2020-2034
- Figure 87. Latin America Macular Edema and Macular Degeneration Market Analysis, By Country, 2020, 2024 and 2034
- Figure 88. Latin America Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
- Figure 89. Middle East & Africa Macular Edema and Macular Degeneration Market Analysis, By Treatment Type, 2020, 2024 and 2034
- Figure 90. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Treatment Type
- Figure 91. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Drug Therapy, 2020-2034
- Figure 92. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Laser Treatment, 2020-2034
- Figure 93. Middle East & Africa Macular Edema and Macular Degeneration Market Analysis, By Application, 2020, 2024 and 2034
- Figure 94. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Application
- Figure 95. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Edema, 2020-2034
- Figure 96. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Diabetic Macular Edema (DME), 2020-2034
- Figure 97. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Cystoid Macular Edema (CME), 2020-2034
- Figure 98. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Macular Degeneration, 2020-2034
- Figure 99. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Dry age-related macular degeneration, 2020-2034
- Figure 100. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Wet age-related macular degeneration, 2020-2034
- Figure 101. Middle East & Africa Macular Edema and Macular Degeneration Market Analysis, By Distribution Channel, 2020, 2024 and 2034
- Figure 102. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Distribution Channel
- Figure 103. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Hospitals, 2020-2034
- Figure 104. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Clinics, 2020-2034
- Figure 105. Middle East & Africa Macular Edema and Macular Degeneration Market (US$ Mn), by Others, 2020-2034
- Figure 106. Middle East & Africa Macular Edema and Macular Degeneration Market Analysis, By Country, 2020, 2024 and 2034
- Figure 107. Middle East & Africa Macular Edema and Macular Degeneration Market Attractiveness Analysis, By Country
- Kubota Pharmaceutical Holdings Co. Ltd
- Alimera Sciences Inc.
- Abbvie Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc.
- Regen X Bio Inc.
- GlaxoSmithKline Plc
- Bayer AG
- Bausch Health Companies Inc.